News PaxMedica, Inc.

Stocks

PXMD

US70424C2035

Biotechnology & Medical Research

Delayed OTC Markets Other stock markets 07:00:00 02/06/2026 pm IST			5-day change	1st Jan Change
0.000500 ^USD	0.00%		0.00%	+400.00%

15/01	PaxMedica, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
06/25/06	PaxMedica, Inc. has Changed its Name to Kuvatris Therapeutics, Inc	CI

All News

Mentions Relevance

15/01	PaxMedica : Quarterly Report for Quarter Ending September 30, 2024 (Form 10-Q)	PU
15/01	PaxMedica, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
06/25/06	PaxMedica, Inc. has Changed its Name to Kuvatris Therapeutics, Inc	CI
05/25/05	PaxMedica, Inc. Announces Board Resignations	CI
07/25/07	Paxmedica, Inc. Announces Resignation of Stephen D. Sheldon as Chief Financial Officer	CI
07/25/07	PaxMedica, Inc. Announces Board Changes	CI
21/24/21	PaxMedica, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
27/24/27	PaxMedica, Inc. Reports First Patient Treated with PAX-101 for Fatal African Sleeping Sickness Infection	CI
20/24/20	PaxMedica, Inc. Announces Resignation of David Hough as Chief Medical Officer	CI
15/24/15	PaxMedica Files Nasdaq Delisting Appeal Notice and Prepares for Upcoming FDA Meeting on PAX-101	AQ
14/24/14	PaxMedica, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
07/24/07	PaxMedica Provides Company Update and Continues to Advance PAX-101 Regulatory Strategy	AQ
06/24/06	PaxMedica, Inc.(NasdaqCM:PXMD) dropped from S&P TMI Index	CI
01/24/01	PaxMedica, Inc.(NasdaqCM:PXMD) dropped from NASDAQ Composite Index	CI
26/24/26	PaxMedica's CEO and Malawi Health Official Discuss Urgent Medical Crisis in Bell2Bell Podcast	AQ
23/24/23	Paxmedica, Inc. Responds to Emergency Request for IV Suramin and Commits to Provide Immediate Access to PAX-101	CI
23/24/23	PaxMedica Responds to Emergency Request for IV Suramin and Commits to Provide Immediate Access to PAX-101	AQ
17/24/17	PaxMedica Receives Emergency Request for IV Suramin from African Health Ministry for Use in Treating Fatal Sleeping Sickness	AQ
17/24/17	PaxMedica, Inc. Receives Emergency Request for IV Suramin from African Health Ministry for Use in Treating Fatal Sleeping Sickness	CI
12/24/12	PaxMedica Achieves Key Milestone in the Development of PAX-101 And Provides Update on Potential NDA Submission	AQ
12/24/12	PaxMedica, Inc. Achieves Key Milestone in the Development of Pax-101 and Provides Update on Potential NDA Submission	CI
23/24/23	PaxMedica : Certificate of Incorporation/Bylaws - Form 8-K	PU
13/24/13	PaxMedica Updated Company Presentation Highlighting Innovations in Autism Spectrum Disorder Treatments	AQ
12/24/12	PaxMedica, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
11/24/11	PaxMedica, Inc. Auditor Raises 'Going Concern' Doubt	CI